Keytruda, also known by its generic name Pembrolizumab, is a groundbreaking immunotherapy drug that has revolutionized the treatment of various cancers. While offering new hope to patients with conditions such as melanoma, lung cancer, and others, the cost of Keytruda treatment has become a significant concern for individuals, healthcare providers,